Xylo Technologies Ltd
XYLO5.010USD
-0.040-0.79%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
1.52MMarket Cap
--P/E TTM
More Details of Xylo Technologies Ltd Company
Xylo Technologies Ltd, formerly known ad Medigus Ltd, is an Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The Company developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).
Company Info
Ticker SymbolXYLO
Company nameXylo Technologies Ltd
IPO dateFeb 27, 2006
CEOMr. Liron Carmel
Number of employees38
Security typeDepository Receipt
Fiscal year-endFeb 27
Address7A Industrial Park,
CityOMER
Stock exchangeNASDAQ Capital Market Consolidated
CountryIsrael
Postal code84965
Phone97286466880
Websitehttps://medigus.com/
Ticker SymbolXYLO
IPO dateFeb 27, 2006
CEOMr. Liron Carmel
Company Executives
Name
Name/Position
Position
Shareholding
Change
Ms. Anat Naschitz
Ms. Anat Naschitz
Director
Director
--
--
Mr. Doron Birger
Mr. Doron Birger
Director
Director
--
--
Efrat Venkert
Efrat Venkert
External Director
External Director
--
--
Yaron Zilberman
Yaron Zilberman
Vice President - Sales and Marketing
Vice President - Sales and Marketing
--
--
Erez Haimovitz
Erez Haimovitz
Director
Director
--
--
Mr. Eitan Machover
Mr. Eitan Machover
Independent Director
Independent Director
--
--
Dr. Minelu Menashe Sonnenschein
Dr. Minelu Menashe Sonnenschein
Vice President - Operations
Vice President - Operations
--
--
Mr. Oded Yatzkan
Mr. Oded Yatzkan
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Liron Carmel
Mr. Liron Carmel
Chief Executive Officer
Chief Executive Officer
--
--
Tatyana Yossef
Tatyana Yossef
Controller
Controller
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Anat Naschitz
Ms. Anat Naschitz
Director
Director
--
--
Mr. Doron Birger
Mr. Doron Birger
Director
Director
--
--
Efrat Venkert
Efrat Venkert
External Director
External Director
--
--
Yaron Zilberman
Yaron Zilberman
Vice President - Sales and Marketing
Vice President - Sales and Marketing
--
--
Erez Haimovitz
Erez Haimovitz
Director
Director
--
--
Mr. Eitan Machover
Mr. Eitan Machover
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2024
FY2023
FY2022
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
United States
15.79M
52.87%
Europe
8.42M
28.20%
Israel
4.86M
16.29%
Great Britain
662.00K
2.22%
Canada
117.00K
0.39%
Other
11.00K
0.04%
By Business
By Region
No Data
Shareholding Stats
Updated: Sun, Feb 23
Updated: Sun, Feb 23
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
L.I.A. Pure Capital Ltd
5.82%
Lepercq de Neuflize Asset Management, LLC
2.03%
Lepercq Corporation Management Ltd
2.03%
UBS Financial Services, Inc.
0.88%
Morgan Stanley & Co. LLC
0.08%
Other
89.16%
Shareholders
Shareholders
Proportion
L.I.A. Pure Capital Ltd
5.82%
Lepercq de Neuflize Asset Management, LLC
2.03%
Lepercq Corporation Management Ltd
2.03%
UBS Financial Services, Inc.
0.88%
Morgan Stanley & Co. LLC
0.08%
Other
89.16%
Shareholder Types
Shareholders
Proportion
Corporation
5.82%
Investment Advisor
4.99%
Research Firm
0.08%
Other
89.11%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
15
139.48K
10.89%
+34.50K
2025Q1
16
137.48K
8.44%
+95.48K
2024Q4
18
58.23K
7.95%
+41.74K
2024Q3
18
6.08K
0.83%
-10.25K
2024Q2
22
3.01K
1.11%
-13.33K
2024Q1
23
1.57K
0.22%
-15.38K
2023Q4
22
1.82K
0.26%
-14.57K
2023Q3
21
1.36K
0.21%
-14.64K
2023Q2
21
981.00
0.15%
-16.23K
2023Q1
21
9.84K
1.60%
-6.21K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
L.I.A. Pure Capital Ltd
74.50K
5.82%
+2.00K
+2.76%
Jun 22, 2025
Lepercq de Neuflize Asset Management, LLC
26.06K
2.03%
--
--
Mar 31, 2025
Lepercq Corporation Management Ltd
26.06K
2.03%
+26.06K
--
Dec 31, 2024
UBS Financial Services, Inc.
11.25K
0.88%
+6.89K
+157.90%
Mar 31, 2025
Morgan Stanley & Co. LLC
986.00
0.08%
-114.00
-10.36%
Mar 31, 2025
Rhumbline Advisers Ltd. Partnership
445.00
0.03%
-28.00
-5.92%
Mar 31, 2025
Osaic Holdings, Inc.
118.00
0.01%
--
--
Mar 31, 2025
SBI Securities Co., Ltd.
32.00
0%
--
--
Mar 31, 2025
UBS Switzerland AG
16.00
0%
--
--
Mar 31, 2025
Morgan Stanley Smith Barney LLC
10.00
0%
--
--
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
4.19M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Dec 09, 2022
XYLO.NB Final Cash Dividend of gross USD 0.85 paid on Dec 28, 2022 going ex on Dec 19, 2022
Dec 20, 2022
Dec 28, 2022
Dec 19, 2022
Stock Split
Date
Type
Ratio
Jul 22, 2024
Merger
2.666666<1
Jul 22, 2024
Merger
2.666666<1
Jul 22, 2024
Merger
2.666666<1
Jul 22, 2024
Merger
2.666666<1
Nov 11, 2022
Merger
15<1
Nov 11, 2022
Merger
15<1
Date
Type
Ratio
Jul 22, 2024
Merger
2.666666<1
Jul 22, 2024
Merger
2.666666<1
Jul 22, 2024
Merger
2.666666<1
Jul 22, 2024
Merger
2.666666<1
Nov 11, 2022
Merger
15<1
Nov 11, 2022
Merger
15<1
Nov 11, 2022
Merger
15<1
Nov 11, 2022
Merger
15<1
